tafluprost
Jump to navigation
Jump to search
Mechanism of action
- fluorinated analog of prostaglandin F2-alpha
- prostaglandin F2-alpha receptor agonists are throught to reduce intraocular pressure by increasing uveosceral outflow[2]
More general terms
More specific terms
References
- ↑ FDA News Release: Feb 14, 2012 FDA approves Zioptan to treat elevated eye pressure http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm291966.htm
- ↑ 2.0 2.1 Zioptan prescribing information Merck Sharp & Dohme http://www.merck.com/product/usa/pi_circulars/z/zioptan/zioptan_pi.pdf